Neogen Corporation (NASDAQ:NEOG) Stock Has Average Price Target of $12.67

Shares of Neogen Corporation (NASDAQ:NEOG) have earned an average recommendation of “Hold” from the five ratings firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $12.67.

A number of equities research analysts have commented on NEOG shares. Guggenheim reiterated a “buy” rating and issued a $14.00 price target (up from $12.00) on shares of Neogen in a research note on Wednesday, September 30th. Wall Street Zen upgraded shares of Neogen from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 3rd. Piper Sandler upgraded shares of Neogen from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $13.00 to $14.00 in a research note on Wednesday, August 26th. Finally, Weiss Ratings raised shares of Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th.

Institutional Investors Weigh In On Neogen

A number of large investors have recently made changes to their positions in the stock. BlackRock Inc. purchased a new stake in Neogen during the 2nd quarter valued at about $300,545,000. Bamco Inc. NY purchased a new position in shares of Neogen during the 2nd quarter valued at about $45,094,000. SG Americas Securities LLC raised its position in Neogen by 287.4% during the first quarter. SG Americas Securities LLC now owns 6,266,033 shares of the company’s stock valued at $58,211,000 after acquiring an additional 4,648,436 shares in the last quarter. Cibc World Market Inc. acquired a new position in Neogen in the second quarter valued at approximately $31,469,000. Finally, Bank of America Corp DE purchased a new stake in Neogen in the 2nd quarter worth approximately $28,280,000. 96.73% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Better-than-expected fiscal Q1 results: Neogen reported revenue of $222.8 million, up 6.5% year over year and ahead of the $208.2 million consensus estimate. Adjusted EPS of $0.08 exceeded expectations by $0.03, while management raised its fiscal 2027 outlook to approximately $885 million-$890 million in revenue and $181 million-$183 million in adjusted EBITDA. Neogen Q1 Revenue Rises 6.5%; Raises FY27 Outlook
• Positive Sentiment: Ambitious long-term targets: At Investor Day, Neogen outlined a strategy focused on food-safety growth, innovation and operating leverage. The company is targeting roughly 30% adjusted EBITDA margins by fiscal 2031 and plans to expand research and development, supporting the view that recurring food-safety demand can drive sustainable growth. Neogen 2026 Investor Day
• Neutral Sentiment: Analyst and market attention remains elevated: Earnings-call discussions focused on execution, margin expansion and the upcoming Petrifilm product transfer. Broader market weakness caused by higher oil prices and Treasury yields may also be affecting trading, although company-specific developments remain the primary catalyst. Neogen FDA warning report
• Negative Sentiment: FDA warning creates significant risk: The FDA warning concerns HYCOAT, a recalled Neogen Vet product reportedly linked to fungal contamination and at least 20 horse deaths. The issue could lead to legal, reputational and financial consequences and has prompted securities-investigation announcements from law firms, increasing uncertainty despite the strong quarter. Neogen securities investigation notice

Neogen Stock Performance

Shares of NEOG stock opened at $11.71 on Friday. Neogen has a 12-month low of $5.37 and a 12-month high of $14.26. The business’s fifty day simple moving average is $12.13 and its 200-day simple moving average is $10.29. The company has a current ratio of 3.90, a quick ratio of 2.91 and a debt-to-equity ratio of 0.37. The company has a market cap of $2.55 billion, a PE ratio of -46.84, a PEG ratio of 4.38 and a beta of 1.79.

Neogen (NASDAQ:NEOG) last posted its quarterly earnings data on Tuesday, October 6th. The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. Neogen had a positive return on equity of 3.29% and a negative net margin of 6.35%.The firm had revenue of $222.80 million during the quarter, compared to analysts’ expectations of $208.18 million. During the same quarter last year, the firm earned $0.04 EPS. The business’s quarterly revenue was up 6.5% on a year-over-year basis. Analysts expect that Neogen will post 0.27 earnings per share for the current fiscal year.

About Neogen

Neogen Corporation is a global provider of food safety and animal safety products and services. The company develops diagnostic tests, laboratory products, and related solutions that help customers detect foodborne pathogens, allergens, toxins, residues, and other contaminants throughout the food production process.

Its food safety portfolio includes test kits, culture media, molecular testing systems, sanitation monitoring products, and laboratory supplies used by food manufacturers, processors, retailers, and regulatory organizations.